Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

Representative before the EPO

Employment test 501 - 1000 employees
Company dna olswang llp
operating since 1981
992.2
Headquarter in London and 8 offices
active in Legal Services and IP Consulting

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Hilary Mary van der Hoff has worked on the following 22 EPO patent applications which have been published in the last five years:

EP11797116

POCHOXIME CONJUGATES USEFUL FOR THE TREATMENT OF HSP90 RELATED PATHOLOGIES

IPC classification:
A61K 31/335, A61K 31/7048, A61P 35/00, C07D 313/00, C07D 495/04, C07H 15/26
Applicant:
Université de Strasbourg
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP11807376

SQUASH LEAF CURL VIRUS (SLCV) RESISTANCE IN CUCURBITS

IPC classification:
A01H 1/00, A01H 1/04, A01H 5/00
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11781363

NITRO FATTY ACIDS - NEUROPROTECTION AND/OR INHIBITION OF COGNITIVE DECLINE

IPC classification:
A23L 1/30, A23L 1/302, A61K 9/48, A61K 31/122, A61K 31/201, A61K 31/202, A61K 31/355, A61K 31/519, A61K 31/557, A61K 31/714, A61K 36/16, A61K 36/258, A61K 45/06
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP12825651

PEG-INTERFERON LAMBDA 1 CONJUGATES

IPC classification:
C07K 11/00, C12P 21/04
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12833767

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 39/00, C07K 16/00, C12P 21/08
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12735490

IMMUNOCYTOKINE COMBINATION THERAPY

IPC classification:
A61K 38/20, A61K 47/48, C07K 14/525, C07K 14/54, C07K 16/18
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11725997

SELECTIVE INTEGRIN INHIBITORS

IPC classification:
A61K 47/48, A61P 29/00, A61P 35/00, A61P 37/00, A61P 43/00
Applicant:
Elan Pharmaceuticals Inc.
Agent:
Hilary Mary van der Hoff, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11875114

METHODS FOR TREATING HYPERURICEMIA IN PATIENTS WITH GOUT USING HALOFENATE OR HALOFENIC ACID AND A SECOND URATE-LOWERING AGENT

IPC classification:
A61K 31/19
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12864819

TAXANE AND ABEO-TAXANE ANALOGS

IPC classification:
A01N 43/52, A61K 31/335, A61K 31/357, C07D 309/00
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP11875217

METHODS FOR TREATING GOUT FLARES

IPC classification:
A01N 37/00, A61K 31/20
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11875027

METHODS FOR TREATING GOUT IN PATIENT SUBPOPULATIONS

IPC classification:
A01N 37/00, A61K 31/20
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12850629

HUMAN NOTCH RECEPTOR MUTATIONS AND THEIR USE

IPC classification:
C07H 21/00, G01N 33/48
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12804651

ACID-LABILE LIPOPHILIC PRODRUGS OF CANCER CHEMOTHERAPEUTIC AGENTS

IPC classification:
A61K 31/265, A61K 47/44, C07D 317/24
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11807988

PHYTOPHTHORA RESISTANCE IN SWEET PEPPERS

IPC classification:
A01H 5/00, C12Q 1/68
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14166833

Metal delivery agents and terapeutic uses of the same

IPC classification:
A61K 31/145, A61K 31/28, A61K 31/30, A61K 31/315, A61K 31/555, A61K 33/30, A61K 33/34, A61P 9/00, A61P 25/00, A61P 31/00, A61P 35/00
Applicant:
University of Melbourne
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12868058

CANCER TREATMENT AND MONITORING METHODS USING OX40 AGONISTS

IPC classification:
A61K 39/00, C12Q 1/68
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12814264

RSPO BINDING AGENTS AND USES THEREOF

IPC classification:
A61K 38/17, A61K 39/395, A61K 45/06, A61P 35/00, C07K 14/71, C07K 16/18, C07K 16/28, C07K 16/30, C07K 16/46, G01N 33/574
Applicant:
OncoMed Pharmaceuticals Inc
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP11822279

CHROMATOGRAPHY METHODS

IPC classification:
B01D 15/16, B01D 15/20, B01D 15/22, B01D 15/32, G01N 30/34, G01N 30/56, G01N 30/60
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP11838481

METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS

IPC classification:
A61K 39/395, G01N 33/566, G01N 33/68
Applicant:
Biogen MA Inc.
Applicant:
Elan Pharmaceuticals Inc.
Applicant:
Biogen Idec MA Inc.
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP11740315

POLYSACCHARIDE BASED ANTIMICROBIAL FORMULATIONS

IPC classification:
A01N 41/06, A61K 31/145, A61K 47/36
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14731098

BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION (AMD)

IPC classification:
G01N 33/68
Agent:
Robert John Stephen, CMS Cameron McKenna Nabarro Olswang LLP
Agent:
Multiple attorneys, Olswang LLP
Status:
EXAMINATION IN PROGRESS
EP11733320

WNT-BINDING AGENTS AND USES THEREOF

IPC classification:
C07K 16/18, C07K 16/22
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature